NURS 6630

A noncompliant patient states, “Why do you want me to put this poison in my body?” Identify the best response made by the psychiatric-mental health nurse practitioner (PMHNP). A “You have to take your medication to become stable.” . B “ Medications work by increasing the types of neurotransmitters produced by the human brain.” . C “Most medications that work in the brain will result in restoring an imbalance of one or more . neurotransmitters that your body al...

1 out of 1 points A noncompliant patient states, “Why do you want me to put this poison in my body?” Identify the best response made by the psychiatric-mental health nurse practitioner (PMHNP). Answer: C. “Most medications that work in the brain will result in restoring an imbalance of one or more neurotransmitters that your body already produces helping to alleviate your symptoms .” Question 2 1 out of 1 points Ms. Hill is currently being treated for schizophrenia but has sto...

 Question 1 0 out of 1 points A patient diagnosed with obsessive compulsive disorder has been taking a high-dose SSRI and is participating in therapy twice a week. He reports an inability to carry out responsibilities due to consistent interferences of his obsessions and compulsions. The PMHNP knows that the next step would be which of the following? Selected Answer: B. Decrease his SSRI and add an MAOI.  Question 2 0 out of 1 points Which statement best describes a pharmaco...

Question1 1 out of 1 points When an unstable patient asks why it is necessary to add medications to his current regimen, the PMHNP’s best response would be: Selected Answer: C. “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in the brain. Often, a single medication may only effect one or two of the dys-functioning systems. The addition of another medication can work with the current medication in stabilizing multiple neurotransmitter syst...

NURS 6630 WEEK 5 IP CASE STUDY 1/ NURS 6630: PSYCOPHARMACOLOGIC APPROACHES TO TREATMENT OF PSYCOPATHOLOGY

(Solution) NURS 6630 Week 10 Assignment: Assessing and Treating Patients With Impulsivity, Compulsivity, and Addiction / A Puerto Rican Woman with Comorbid Addiction. Assessing and Treating Patients with Impulsivity, Compulsivity, and Addiction Course: NURS-6630- Psychopharmalogical Approaches to Treat Psychopathology Week 10: Assignment 1 Walden University Introduction The provided case study is of Mrs. Maria Perez who is 53 years old Puerto Rican female. ...

(Solution) NURS 6630 Week 9 Assessing and Treating Clients With Attention Deficit Hyperactivity Disorder – Young Girl With ADHD/ Katie is an 8 year old Caucasian female. Assessing and Treating Clients with Attention Deficit Hyperactive Disorder (ADHD) Tasiana Malya Walden University NURS 6630, Psychopharmacologic Approaches to Treatment of Psychopathology April 22nd, 20

(Solution) NURS 6630 Week 8 Assignment 2: Assessing and Treating Patients with Sleep/Wake Disorders ( a 31-year-old male who presents to the office with a chief complaint of insomnia.) Assessing and Treating Patients with Sleep/Wake Disorders Course: NURS-6630- Psychopharmalogical Approaches to Treat Psychopathology Week 8: Assignment 2 Walden

(solved) NURS 6630 Week 4 Assignment: Assessing and Treating Pediatric Patients With Mood Disorders; The client is an 8-year-old African American male who arrives at the ER with his mother. He is exhibiting signs of depression.2022 Assignment: Assessing and Treating Pediatric Patients with Mood Disorders Manvir Pannu Walden University NURS 6630: Psychopharmalogical Approaches to Treat Psychopathology Aaron Weiner December 28, 2020 Assignment : Assessing and Treating Pedia...

(Solution) NURS 6630 week 2 Discussion: Foundational Neuroscience, latest 2021/2022. Explain the agonist-to-antagonist spectrum of action of psychopharmacologic agents, including how partial and inverse agonist functionality may impact the efficacy of psychopharmacologic treatments. The traditional drug-receptor theory is a concept of how drugs abide, drug- receptor interaction, and agonists' actions and antagonists with affinity and intrinsic efficacy (Berg, & Clarke, 2018). Berg and Cla...